EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association between Anti-Helicobacter pylori IgG seropositivity on coronary heart disease and potential pathogenesis: a Mendelian randomization study

Jing Wang, Tianying Chang, Yiqiang Wang, Jinling Zhang, Rui Chen, Le Liu, Yingzi Cui, Hongguang Jin

PLOS One · 2025

DOI: 10.1371/journal.pone.0329137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Jing Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Changchun University of Chinese Medicine, Changchun, China. Hauptthemen laut MEDLINE: Helicobacter pylori, Immunoglobulin G, Coronary Disease, Helicobacter Infections. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Commission of Jilin Province, Chinese Medicine Evidence Based Capacity Enhancement Program (2024) of the Affiliated Hospital to Changchun University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Currently, observational studies and clinical trials have shown that the occurrence of coronary heart disease (CHD) is closely related to anti-Helicobacter pylori (H. pylori) IgG seropositivity, but these studies may be affected by confounding factors, resulting in a causal relationship that is still controversial.

Methods

We conducted a Mendelian randomization analysis to clarify the association between anti-H. pylori IgG seropositivity and CHD and explore its potential pathogenesis. Exposure, outcome, and mediator data were obtained all from the genome-wide association studies (GWAS) summary data. The inverse variance weighting (IVW) analysis method under the fixed-effect model was used as our primary statistical method. Other statistical methods are supplements, such as IVW under the random-effects model, weighted median, and MR-Egger regression method. Causal estimates are presented as odds ratios (ORs) with 95% confidence intervals (CIs). To ensure the stability and reliability of the results, we also performed sensitivity and heterogeneity analysis.

Results

This study shows that increases of anti-H. pylori IgG seropositivity was significantly associated with an increased risk of CHD (OR=1.003, 95% CI:1.0001.006, P = 0.048) and increases in peak insulin response (β = 0.214, 95% CI: 0.025–0.403, P = 0.026), decrease in total free cholesterol levels (β = ‒0.031, 95% CI: ‒0.061 to ‒0.000, P = 0.045), decreased waist circumference (β = ‒0.073, 95% CI: ‒0.138 to ‒0.008, P = 0.027) and waist-to-hip ratio (β = ‒0.069, 95% CI: ‒0.136 to ‒0.002, P = 0.044). The leave-one-out method proved inadequate in detecting instances where a single SNP exhibited a bias towards or dependency on the causation. Furthermore, our findings revealed no heterogeneity or pleiotropy.

Conclusion

Our MR study provided strong evidence of a causal relationship between anti-H. pylori IgG seropositivity and related to an increased risk of CHD. The effect of anti-H. pylori IgG seropositivity on CHD may be related to a higher peak insulin response or lower total free cholesterol levels and a decrease in waist circumference and waist-to-hip ratio. However, further research is needed to prove the results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriImmunoglobulin GCoronary DiseaseHelicobacter InfectionsAntibodies, BacterialHumansMendelian Randomization AnalysisGenome-Wide Association StudyRisk Factors

Substanzen

Immunoglobulin GAntibodies, Bacterial

Autor:innen und Institutionen

  • Changchun University of Chinese Medicine, Changchun, China.
  • EBM office, the Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.
  • Department of Cardiology, the Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.

Förderung

  • Health Commission of Jilin Province
  • Chinese Medicine Evidence Based Capacity Enhancement Program (2024) of the Affiliated Hospital to Changchun University of Chinese Medicine

Zitieren

APA

Wang, J., Chang, T., Wang, Y., Zhang, J., Chen, R., Liu, L., Cui, Y., & Jin, H. (2025). Association between Anti-Helicobacter pylori IgG seropositivity on coronary heart disease and potential pathogenesis: a Mendelian randomization study. PLOS One. https://doi.org/10.1371/journal.pone.0329137

Vancouver

Wang J, Chang T, Wang Y, Zhang J, Chen R, Liu L, et al. Association between Anti-Helicobacter pylori IgG seropositivity on coronary heart disease and potential pathogenesis: a Mendelian randomization study. PLOS One. 2025. doi:10.1371/journal.pone.0329137

BibTeX
@article{Wang2025,
  author = {Wang, Jing and Chang, Tianying and Wang, Yiqiang and Zhang, Jinling and Chen, Rui and Liu, Le and Cui, Yingzi and Jin, Hongguang},
  title = {Association between Anti-Helicobacter pylori IgG seropositivity on coronary heart disease and potential pathogenesis: a Mendelian randomization study},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0329137}
}
Kostenlos starten →